04/30/2011
Nisha Chhabria, MD; Michel T. Torbey, MD, MPH
<p><strong>ABSTRACT: Establishing the time of symptom onset is essential to selecting the appropriate therapy. Intravenous tissue-type plasminogen activator (t-PA), administered within 3 hours...
